Compare RKT & NTRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RKT | NTRA |
|---|---|---|
| Founded | 1985 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Medical Specialities |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 41.9B | 39.1B |
| IPO Year | 2020 | 2015 |
| Metric | RKT | NTRA |
|---|---|---|
| Price | $14.66 | $277.78 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 16 | 15 |
| Target Price | $20.40 | ★ $259.07 |
| AVG Volume (30 Days) | ★ 34.4M | 1.6M |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 0.65 |
| EPS | ★ 0.10 | N/A |
| Revenue | N/A | ★ $210,939,000.00 |
| Revenue This Year | $66.40 | $18.08 |
| Revenue Next Year | $8.18 | $19.65 |
| P/E Ratio | $146.50 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $12.17 | $131.81 |
| 52 Week High | $24.36 | $288.04 |
| Indicator | RKT | NTRA |
|---|---|---|
| Relative Strength Index (RSI) | 51.92 | 66.39 |
| Support Level | $13.63 | $186.96 |
| Resistance Level | $14.67 | $288.04 |
| Average True Range (ATR) | 0.72 | 10.93 |
| MACD | -0.08 | -0.91 |
| Stochastic Oscillator | 34.16 | 69.79 |
Rocket Companies is a financial services company that was originally founded as Rock Financial in 1985 and is currently based in Detroit. Rocket Companies offers a wide array of services and products but is best known for its Rocket Mortgage business. The company's mortgage lending operations are split between its direct-to-consumer lending, which sees borrowers accessing the company's lending arm directly through either its mobile app or website, and its partner network where mortgage brokers and other firms use Rocket's origination process to offer loans to their customers. The company has rapidly gained market share in recent years and will also be the largest mortgage servicer in the US following its acquisition of the Mr. Cooper Group.
Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.